Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease

Affiliations

• ¹ Department of Pharmaceutics, University of Washington, Seattle, WA, USA.
• ² Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA. Andrew.Annalora@oregonstate.edu.
• ³ Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
• ⁴ Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
• ⁵ Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ⁶ Depto Clinica Medica, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, Brazil.
• ⁷ Kidney Research Institute, University of Washington, Seattle, WA, USA.
• ⁸ Department of Pharmaceutics, University of Washington, Seattle, WA, USA. Edkelly@uw.edu.